Max Healthcare Institute

1,298.20
-3.20
(-0.25%)
ann
There are 3 new updates from the company13 hours ago
Viewcross
right
Market Cap
1,26,515.20 Cr
EPS
11.07
PE Ratio
111.47
Dividend Yield
0.12 %
52 Week High
1,308.60
52 Week Low
836.60
PB Ratio
13.45
Debt to Equity
0.13
Sector
Hospitals
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from20 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+65.00 %
+65.00 %
Hold
Hold+15.00 %
+15.00 %
Sell
Sell+20.00 %
+20.00 %
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,298.20
#1 1,26,515.20
#9 111.47
#3 7,028.46
#3 18.77
#3 1,070
#4 26.84
66.67
7,553.50
1,08,773.10
75.12
#1 21,794.00
14.74
1,513
60.41
70.65
807.05
59,947.50
71.95
7,782.75
8.99
809
-7.43
67.42
2,011.40
40,992.70
#1 51.59
5,482.98
10.96
807
3.41
55.67
633.15
33,680.50
88.45
4,138.46
22.85
#1 5,417
#1 3,986.36
66.33
1,183.80
31,978.00
61.28
3,692.32
#1 25.09
486
-20.35
52.92
686.05
26,959.40
72.89
3,035.10
12.94
409
48.39
57.58
1,599.40
16,107.10
68.30
1,566.90
17.46
244
10.57
66.99
1,506.50
9,772.60
52.43
1,290.20
17.77
194
-0.88
55.50
566.30
7,631.60
177.55
2,218.14
12.97
28
-71.06
58.80
Forecast
Actual
Growth Rate
Revenue Growth
18.77 %
Net Income Growth
-4.16 %
Cash Flow Change
-12.64 %
ROE
-15.51 %
ROCE
4.66 %
EBITDA Margin (Avg.)
1.91 %

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total Assets
1,453
2,217
3,160
3,314
3,366
3,824
8,544
9,189
10,102
12,000
15,215
Fixed Assets
740
1,478
2,244
2,227
2,192
2,380
6,536
7,018
7,039
8,784
8,922
Current Assets
383
289
349
454
447
768
1,125
1,000
1,943
1,706
1,593
Capital Work in Progress
18
12
46
38
87
6
27
151
252
553
901
Investments
143
0
0
0
1
1
1
1
1
2
106
Other Assets
552
728
870
1,049
1,086
1,439
1,981
2,020
2,810
2,661
0
Total Liabilities
1,453
2,217
3,160
3,314
3,366
3,824
8,544
9,189
10,102
12,000
15,215
Current Liabilities
282
419
381
477
1,140
1,474
777
757
1,046
1,249
1,814
Non Current Liabilities
339
672
1,660
1,806
1,262
1,363
2,129
2,149
1,647
2,343
4,020
Total Equity
832
1,127
1,119
1,031
963
987
5,639
6,283
7,410
8,408
9,381
Reserve & Surplus
343
587
655
627
426
450
4,673
5,313
6,439
7,436
8,409
Share Capital
489
533
537
537
537
537
966
970
971
972
972

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
16
-40
4
-6
-2
267
516
-318
893
-395
Investing Activities
-194
-364
-104
-124
-17
-127
206
-764
-102
-1,253
Operating Activities
64
53
156
166
89
250
118
741
1,284
1,122
Financing Activities
145
271
-48
-48
-74
144
191
-294
-289
-264

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Promoter
70.46 %
70.46 %
60.91 %
60.68 %
50.64 %
50.64 %
23.80 %
23.78 %
23.77 %
23.76 %
23.76 %
23.75 %
23.75 %
23.74 %
23.74 %
23.74 %
23.74 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.01 %
0.01 %
0.01 %
0.00 %
0.01 %
0.01 %
57.33 %
56.98 %
57.29 %
56.93 %
54.74 %
DIIs
4.86 %
7.93 %
8.70 %
15.60 %
17.49 %
19.26 %
21.00 %
20.47 %
19.35 %
11.90 %
11.32 %
11.34 %
14.96 %
15.36 %
15.14 %
15.55 %
17.58 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
5.18 %
5.76 %
5.20 %
5.23 %
5.41 %
4.94 %
4.54 %
4.36 %
3.72 %
3.54 %
3.55 %
3.34 %
3.29 %
3.24 %
3.18 %
3.13 %
3.31 %
Others
19.50 %
15.84 %
25.18 %
18.49 %
26.46 %
25.16 %
50.65 %
51.38 %
53.15 %
60.80 %
61.36 %
61.56 %
0.67 %
0.67 %
0.65 %
0.64 %
0.63 %
No of Share Holders
45,339
70,655
91,937
1,11,877
1,20,079
1,05,000
1,01,659
1,11,701
1,04,656
1,11,374
1,18,635
1,11,338
1,27,009
1,36,254
1,37,856
1,40,028
1,51,633

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1 1.5 0.00
Dividend Yield (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.12 0.14 0.00

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
30 Jul 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
30 Jul 2025 1,197.50 1,297.55
04 Jul 2025 DIVIDEND Dividend
₹ 1.50 /share
04 Jul 2025 1,164.70 1,297.55
20 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
20 May 2025 1,172.50 1,164.70
30 Jan 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
30 Jan 2025 1,055.75 1,043.85
05 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
05 Nov 2024 992.55 1,044.20
20 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
20 Sept 2024 882.75 1,067.95
23 Aug 2024 DIVIDEND Dividend
₹ 1.50 /share
23 Aug 2024 838.30 852.95
27 Sept 2023 ANNUAL GENERAL MEETING Annual General Meeting
NA
27 Sept 2023 553.60 573.60
08 Sept 2023 DIVIDEND Dividend
₹ 1.00 /share
08 Sept 2023 506.90 603.00

Announcements

Business Responsibility and Sustainability Reporting (BRSR)11 hours ago
Reg. 34 (1) Annual Report.13 hours ago
Notice Of 24Th Annual General Meeting And Integrated Annual Report For The Financial Year 2024-2513 hours ago
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 20153 days ago
Closure of Trading Window8 days ago
Announcement under Regulation 30 (LODR)-Newspaper Publication8 days ago
Intimation Of Annual General Meeting Record Date And Communication To Members For Deduction Of Tax At Source On Final Dividend10 days ago
Intimation Of Annual General Meeting Record Date And Communication To Members For Deduction Of Tax At Source On Final Dividend10 days ago
Announcement under Regulation 30 (LODR)-Change in ManagementJun 17, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationMay 31, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 27, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptMay 27, 2025
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 23, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 21, 2025
Audio Recording Of Earnings Call Held On May 21 2025May 21, 2025
Appointment Of Secretarial Auditor And Cost AuditorMay 20, 2025
Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/sMay 20, 2025
Presentation On Earnings UpdateMay 20, 2025
Results For Quarter And Financial Year Ended March 31 2025May 20, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 20, 2025
Board Meeting Outcome for Meeting Held On May 20 2025May 20, 2025
Execution Of Sale Deed For Acquisition Of Land And Building Situated In Uttar Pradesh By Crosslay Remedies LimitedMay 16, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 13, 2025
Board Meeting Intimation for Financial Results And Recommendation Of Final DividendMay 13, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSMay 11, 2025
Rumour verification - Regulation 30(11)May 06, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 07, 2025
Announcement under Regulation 30 (LODR)-Credit RatingApr 01, 2025
Closure of Trading WindowMar 26, 2025
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Mar 22, 2025
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Mar 14, 2025
Outcome Of Board MeetingMar 12, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 27, 2025
Approval Of Scheme Of Amalgamation Between ALPS Hospital Limited And Max Hospitals And Allied Services LimitedFeb 26, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 24, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementFeb 18, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 14, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationFeb 11, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 06, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 03, 2025
Announcement under Regulation 30 (LODR)-Updates on AcquisitionJan 31, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 31, 2025
Audio Recording Of Earnings Call Held On January 31 2025Jan 31, 2025
Integrated Filing (Financial)Jan 30, 2025
Agreement To Lease For Setting Up ~500 Bedded Build-To-Suit Hospital At Thane MaharashtraJan 30, 2025
Presentation On Earnings UpdateJan 30, 2025
Announcement under Regulation 30 (LODR)-AcquisitionJan 30, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJan 30, 2025
Board Meeting Outcome for Meeting Held On January 30 2025Jan 30, 2025
Results- Financial Results For Quarter And Nine Months Ended December 31 2024Jan 30, 2025

Technical Indicators

RSI(14)
Neutral
66.67
ATR(14)
Less Volatile
36.50
STOCH(9,6)
Overbought
87.01
STOCH RSI(14)
Overbought
94.58
MACD(12,26)
Bullish
6.75
ADX(14)
Strong Trend
26.33
UO(9)
Bearish
52.85
ROC(12)
Uptrend And Accelerating
9.86
WillR(14)
Overbought
-9.96

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
HDFC Mid Cap Fund Direct-Growth
0.00%
-4000000
-0.59%
-1.68%
Kotak Arbitrage Fund Direct-Growth
0.66%
-1399125
-0.27%
0.28%
SBI Equity Hybrid Fund Direct Plan-Growth
1.04%
-900000
-0.13%
-0.15%
Invesco India Arbitrage Fund Direct-Growth
0.30%
-528150
-0.32%
-0.01%
Tata Balanced Advantage Fund Direct - Growth
0.44%
397000
0.44%
0.44%
Edelweiss Mid Cap Direct Plan-Growth
3.35%
307716
0.17%
-0.05%
SBI Arbitrage Opportunities Fund Direct-Growth
0.24%
-263550
-0.10%
-0.07%
HDFC Arbitrage Fund Wholesale Direct-Growth
0.68%
229425
0.11%
0.34%
Baroda BNP Paribas Multi Cap Fund Direct-Growth
0.99%
-200000
-0.84%
-0.90%
Canara Robeco Large and Mid Cap Fund Direct-Growth
2.02%
-145779
-0.10%
-0.18%
ICICI Prudential Equity Arbitrage Direct-Growth
0.14%
130200
0.05%
0.07%
Tata Mid Cap Direct Plan-Growth
1.95%
116000
0.24%
0.18%
WhiteOak Capital Mid Cap Fund Direct - Growth
2.46%
-115086
-0.60%
-0.79%
Kotak Debt Hybrid Fund Direct -Growth
0.40%
112500
0.40%
0.40%
Mirae Asset Arbitrage Fund Direct - Growth
0.20%
-100275
-0.38%
-0.36%
Tata Arbitrage Fund Direct - Growth
0.43%
-96075
-0.11%
0.14%
TRUSTMF Flexi Cap Fund Direct - Growth
0.94%
92566
0.94%
0.94%
Mahindra Manulife Multi Cap Fund Direct - Growth
1.12%
90000
0.15%
0.46%
HSBC Large and Mid Cap Fund Direct - Growth
3.32%
87618
0.10%
-0.01%
Edelweiss Large & Mid Cap Direct Plan-Growth
2.24%
81101
0.18%
0.11%
Bandhan Large Cap Fund Direct-Growth
0.00%
-79819
-0.48%
-0.48%
Aditya Birla Sun Life Pharma & Healthcare Fund Direct-Growth
0.97%
70000
0.97%
0.97%
UTI Healthcare Fund Direct-Growth
2.67%
61067
0.65%
0.66%
HSBC Multi Cap Fund Direct - Growth
0.14%
60000
0.14%
0.14%
Invesco India Large & Mid Cap Fund Direct-Growth
3.40%
51674
-0.08%
-0.26%

About Max Healthcare Institute

Max Healthcare Institute Limited is an Indian integrated healthcare provider operating a network of healthcare facilities, primarily in North India. The company offers a range of medical services including primary, secondary, tertiary, and quaternary care across various specialties. It operates 17 healthcare facilities in Delhi NCR, Haryana, Punjab, Uttarakhand, and Maharashtra. Max Healthcare has two strategic business units: Max Lab, which provides diagnostic services outside its hospital network, and Max@Home, offering health and wellness services at home. The company is listed on the BSE and NSE, with Mr. Abhay Soi and Kayak Investments Holding Pte. Ltd. as its current promoters.
Chairperson NameAbhay Soi